Massivemarkets

Nasdaq: LTGO · Listed Aug 7, 2026

Latigo Biotherapeutics IPO

IPO price

$18.00

Latigo Biotherapeutics (LTGO) priced its IPO at $18.00 a share and has traded on Nasdaq since Aug 7, 2026.

LTGO today$13.31-26.06%since IPO15-min delayed · as of 5:19:44 PM EST on Nov 18, 2026

See the LTGO quote

First trading day · Aug 7, 2026

IPO price 18.00VWAP 19.84first trade 21.00+16.67% from the IPO pricehigh 21.05$18.25volume · rising bars above the line, falling bars below143.23K11:404:00
IPO price
$18.00
the top of the range of $16 to $18
First trade
$21.00
+16.67% from the IPO price
First-day last trade
$18.25
+1.39% from the IPO price, regular session
Raise
$345.6M
before the underwriters' option

These numbers are from the first trading day, Aug 7, 2026.

How LTGO did against the market

LTGO against the market, from its first trade at 11:40 ET to the last trade of the session.

LTGO from its first trade
-13.10%
Against the market (QQQ)
-13.1 pts

LTGO fell 13.1% from its first trade to the last trade of the session. That is 13.1 points worse than the market.

Same-day moves do not show that LTGO caused them. The market is QQQ, the Nasdaq-100 ETF.

The debut race

LTGO against other big listings, as the percent change from each stock's own IPO price.

The first 30 trading days. Each point is the last regular-session trade of a day.

+50%+100%+150%+200%+250%IPOday 1day 5day 10day 15day 20day 25day 30Figma '25 +69.64%Reddit '24 +40.32%CoreWeave '25 +28.42%Arm '23 -3.06%Klarna '25 -7.33%LTGO +24.39%

The IPO scoreboard

LTGO against 6 other big listings: the return from each IPO's own price at the first trade, the close of day 1, day 5, and day 30.

LTGO against other big IPOs: the money raised, and the return from each IPO price at the first trade, at the last trade of day 1, and on day 5 and day 30.
IPORaisedFirst tradeDay 1 closeDay 1 close, as a barDay 5Day 30
Latigo Biotherapeutics '26$345.6M+16.67%+1.39%+11.17%+24.39%
Figma '25$1.22B+157.58%+252.42%+173.64%+69.64%
Circle '25$1.05B+122.58%+168.45%+278.18%+622.98%
Reddit '24$748M+38.24%+47.97%+69.90%+40.32%
Arm '23$5.23B+10.00%+23.76%+3.63%-3.06%
Klarna '25$1.37B+30.00%+16.14%+13.73%-7.33%
CoreWeave '25$1.5B-2.50%+0.02%+34.32%+28.42%

Day 1 is the last regular-session trade of the first day. Day 5 and day 30 are the last trade of the fifth and thirtieth trading day, counting the listing day as day 1. A cell fills in when that day has traded.

The offering

The Latigo Biotherapeutics IPO offers 19.2M shares to raise $345.6M, before any underwriters' option.

$14$16$17$18$20
Expected price range
$16 to $18
IPO price
$18.00
Shares offered
19.2M
Money raised
$345.6M
Listing date
Aug 7, 2026
Exchange
Nasdaq
Security
Ordinary Shares

Money raised, against the largest IPOs

  • Alibaba '14$21.77B
  • Facebook '12$18.41B
  • Rivian '21$11.93B
  • Uber '19$8.1B
  • Arm '23$5.23B
  • Latigo Biotherapeutics$345.6M

Where LTGO ranks

Latigo Biotherapeutics's market cap against the largest US-listed companies.

Market cap, against the largest US-listed companies

  • AAPL$5.12T
  • MSFT$3.77T
  • NVDA$3.65T
  • GOOGL$3.47T
  • AMZN$2.9T
  • TSM$1.88T
  • AVGO$1.69T
  • META$1.58T
  • TSLA$1.52T
  • BRK.B$1.22T
  • LTGO$882.44M

Filings and the company

What Latigo Biotherapeutics has disclosed to the SEC, and the basic facts about the listing.

8-K filings

Material events that Latigo Biotherapeutics discloses to the SEC on Form 8-K.

  • On November 5, 2026, Latigo Biotherapeutics, Inc. (the "Company") issued a press release announcing its financial results for the quarter ended September 30, 2026.

  • On September 3, 2026, Latigo Biotherapeutics, Inc. (the "Company") issued a press release announcing its financial results for the quarter ended June 30, 2026.

  • Public offeringAug 10, 2026

    On August 10, 2026, the Company completed its IPO of an aggregate of 19,200,000 shares of common stock at a price to the public of $18.00 per share. The aggregate gross proceeds from the IPO, before deducting underwriting discounts and commissions and estimated offering expenses payable by the Company, were approximately $345.6 million.

About Latigo Biotherapeutics

Latigo Biotherapeutics Inc is a clinical-stage biotechnology company focused on developing non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its flagship product candidates, LTG-001 and LTG-321, are oral Nav1.8 inhibitors being developed for the treatment of acute pain. The company is also developing additional Nav1.8 inhibitor candidates using alternative formulations and delivery approaches.

Ticker
LTGO
Exchange
Nasdaq
Market
stocks
Type
CS
Currency
USD
Industry
PHARMACEUTICAL PREPARATIONS
Listed
Aug 7, 2026
Security
Ordinary Shares
Company website

Frequently asked questions

What was the Latigo Biotherapeutics IPO price?

$18.00 a share.

When did Latigo Biotherapeutics go public?

Latigo Biotherapeutics listed on Nasdaq on Aug 7, 2026 under the ticker LTGO.

How much did the Latigo Biotherapeutics IPO raise?

$345.6M, before any underwriters' option.

How did Latigo Biotherapeutics open on its first day?

LTGO first traded at $21.00, +16.67% from the IPO price of $18.00.

How did LTGO close on its first day?

Its last regular-session trade was $18.25, +1.39% from the IPO price of $18.00.

What was the LTGO first-day trading range?

$18.19 to $22.47 in the regular session.

How many LTGO shares traded on the first day?

3.23M shares in the regular session.

How many shares did Latigo Biotherapeutics sell in its IPO?

19.2M shares.

How did LTGO do against the market on its first day?

LTGO fell 13.1% from its first trade to the last trade of the session. That is 13.1 points worse than the market (QQQ, the Nasdaq-100 ETF).

What exchange is LTGO listed on?

Latigo Biotherapeutics lists on Nasdaq under the ticker LTGO.

Build with Massive

Get the LTGO data behind this page

The Massive endpoint behind each section of this page
What the page showsEndpoint
Offering terms and dates/vX/reference/ipos
Price/v3/snapshot
Chart, VWAP, and the market comparison/v2/aggs/ticker/LTGO/range/5/minute
Market cap/v3/reference/tickers/LTGO
News/v2/reference/news
Filings/vX/disclosures

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.